Next Article in Journal
Caco-2 Cell Line Standardization with Pharmaceutical Requirements and In Vitro Model Suitability for Permeability Assays
Next Article in Special Issue
Modulation of Brain Cholesterol Metabolism through CYP46A1 Overexpression for Rett Syndrome
Previous Article in Journal
Tailoring Risperidone-Loaded Glycethosomal In Situ Gels Using Box–Behnken Design for Treatment of Schizophrenia-Induced Rats via Intranasal Route
 
 
Review

Article Versions Notes

Pharmaceutics 2023, 15(11), 2522; https://doi.org/10.3390/pharmaceutics15112522
Action Date Notes Link
article xml file uploaded 24 October 2023 08:01 CEST Original file -
article xml uploaded. 24 October 2023 08:01 CEST Update -
article pdf uploaded. 24 October 2023 08:01 CEST Version of Record -
article xml file uploaded 24 October 2023 08:03 CEST Update -
article xml uploaded. 24 October 2023 08:03 CEST Update -
article pdf uploaded. 24 October 2023 08:03 CEST Updated version of record -
article html file updated 24 October 2023 08:03 CEST Original file -
article xml file uploaded 24 October 2023 08:03 CEST Update -
article xml uploaded. 24 October 2023 08:03 CEST Update -
article pdf uploaded. 24 October 2023 08:03 CEST Updated version of record -
article html file updated 24 October 2023 08:04 CEST Update -
article xml file uploaded 24 October 2023 08:04 CEST Update -
article xml uploaded. 24 October 2023 08:04 CEST Update https://www.mdpi.com/1999-4923/15/11/2522/xml
article pdf uploaded. 24 October 2023 08:04 CEST Updated version of record https://www.mdpi.com/1999-4923/15/11/2522/pdf
article html file updated 24 October 2023 08:05 CEST Update -
article html file updated 24 October 2023 08:06 CEST Update https://www.mdpi.com/1999-4923/15/11/2522/html
Back to TopTop